2025 annual financial data
Traws Pharma 2025 Net margin
Direct answer
Net margin was 328.67%.
Operating income was -17,875,000 USD and net income was 9,170,000 USD.
Operating cash flow was -18,185,000 USD.
Get free Traws Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,790,000 USD
- Operating income
- -17,875,000 USD
- Net income
- 9,170,000 USD
- Operating cash flow
- -18,185,000 USD